The contribution of digital health to net zero patient care in allergic diseases: From concept to practice DOI Open Access
Jean Bousquet, Tari Haahtela, Josep M. Antó

et al.

Allergy, Journal Year: 2023, Volume and Issue: 79(2), P. 281 - 285

Published: Sept. 15, 2023

There is growing awareness of the need to deliver cost-effective, high-quality, zero-carbon health care.1 The healthcare system needs leverage developments in digital improve cost-effectiveness. This could contribute reducing greenhouse gas (GHG) emissions, and represents a key strategy fight against climate crisis. term ‘digital health’ includes advanced medical technologies, disruptive innovations, communication tools, all aiming provide best practices. Choosing be carbon-free—either mission driven or motivated by economics—has potential directly indirectly impact well-being patients. Green innovation has become one most important approaches achieving sustainable development modern life.2 Environmental regulation largely impacts green technology innovation. Healthcare delivery been recognized as major area opportunity for decarbonizing care, an where there enormous develop zero_carbon ‘digitally-enabled, patient-centred care’. sources CHG emissions environmental on care are those due hospitals medicines.3 As any disease, ‘going green' (i) improvement, design, construction facilities; (ii) daily operations such cleaning, maintenance, many clinical functions; (iii) purchasing, food transportation.2, 4 Becoming each these areas can potentially benefit patient health. Moreover, specific actions targeted at patients with allergic diseases, related use inhaled medication. Telemedicine make greener.5 Although proposed diseases before COVID-19 pandemic, telemedicine was shown effective supporting keeping patient/doctor relationships fruitful.6, 7 contribution decarbonize imbedded concept planetary In 2015, Rockefeller Foundation-Lancet Commission launched novel approach called health, concept, strategy, action plan. To safeguard human Anthropocene epoch, Planet should go together.8 A conference entitled ‘Europe That Protects: Safeguarding Our Planet, Health’ based event co-organized 2019 Finnish Institute Health Welfare, Environment Institute, European (Directorate General Research Development) under auspices Finland's Presidency Union.9, 10 It brought together stakeholders—including researchers, policy makers, regulators—to identify discuss: scientific challenges involved harvesting enhancing benefits sound environment overcoming threats main outcomes consisted recommendations research priorities EU Member States order enable collaborative work protect both our planet. strategies would that co-benefit sharp contrast co-harm humans (Figure 1). Other activities have opposite expense causing harm Planet. involves understand harms Earth's natural systems will ultimately negative Allergy Programme (FAP), Good Practice DG Food Safety (EU), developed from 2008 2018 aim burden diseases.11 hallmark programme emphasis tolerance resilience (instead traditional concepts) way promote preservation prevent medicalization mild symptoms. Importantly, FAP included improving contact nature its principles, becoming precursor (Table collaborated MASK (Mobile Airways Sentinel networK) tool MASK-air® networK rhinitis asthma) project Innovation Partnership Active Healthy Ageing (EIP-on-AHA, Santé CONNECT).12 (the Directorate-General Safety) digitally-enabled, pathways. example cross-border exchange real-world data experience, care13 2). side meeting Finland, symposium—organized final POLLAR (Impact air POLLution Asthma Rhinitis, EIT Health) meeting14, 15—explored transformation sustain airway diseases.16 integration information tools climate, weather, pollution, aerobiology considered inform well allergy systems. latter illustrated pressurized metered-dose inhalers (MDIs), which much higher carbon footprint than dry powder (DPIs).17 Integrating mHealth apps into asthma chronic obstructive pulmonary disease likely reduce unnecessary extra reliever medications.18 Plant species vary different conditions, warning being CATALYSE. distribution pollen trends used assess change public early about beginning season.19 SILAM (System Integrated modeLling Atmospheric composition) global-to-mesoscale dispersion model Meteorological (FMI).20 provides quantitative atmospheric pollution anthropogenic origin, particularly allergenic concentrations. combined MASK-air forecasts. new Horizon Europe grant, CATALYSE (Climate Action Advance HeaLthY Societies Europe; grant agreement number 101057131), started September 2022, aims better understanding defining ways counteract it. One objectives this predictive models effectiveness adaptation change. focused (CATALYSE Task 3.2). stems collaboration between FMI (Finland), Porto University (Portugal), SAS (France), ISGlobal (Spain), Hertie School (Germany), Zurich (Switzerland). implemented support EAACI. tested Lahti, capital region Päijänne Tavastia (Päijät-Häme), economic hubs Finland. Lahti's journey towards forerunner issues began restoration Lake Vesijärvi late 1970s 1980s. Since then, Lahti among first participate environment-related projects over years. therefore city Finland win Capital Award 2021 (https://www.lahti.fi/en/blog/lahti-home-of-planetary-health-and-lifestyle-medicine/). latest effort, Nature Step Health—Lahti Regional 2022–2032, combines promotion stopping loss mitigating spirit indicator asthma, diabetes, obesity, depression. practical require citizens favour healthy diet, increase physical activity mobility, housing environment, encourage contacts nature. regional wellbeing authorities implementing City Campus.21 Real-world official registers, questionnaire surveys carried out. Cross-sectional research, services, nature-based solutions sustainability promoted. Jean Bousquet G. Walter Canonica topic provided outline paper. wrote Tari Haahtela Josep M. Anto were part think tank process their help Hanna Haveri, Mika Makela, Francesca Puggioni Rodolphe Bourret expertise authors thank Ms. Anna Bedbrook English revision TH reports lecturing fee Orion Pharma. None declared. Data sharing not applicable article no created analyzed study.

Language: Английский

Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air®approach DOI Creative Commons
Jean Bousquet,

Josep M Antó,

Bernardo Sousa‐Pinto

et al.

Clinical and Translational Allergy, Journal Year: 2023, Volume and Issue: 13(1)

Published: Jan. 1, 2023

MASK-air

Language: Английский

Citations

34

Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study DOI Creative Commons
Bernardo Sousa‐Pinto, Elı́sio Costa, Rafael José Vieira

et al.

Clinical & Experimental Allergy, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 16, 2025

Adherence to rhinitis treatment has been insufficiently assessed. We aimed use data from the MASK-air mHealth app assess adherence oral antihistamines (OAH), intra-nasal corticosteroids (INCS) or azelastine-fluticasone in patients with allergic rhinitis. included regular European users self-reported and reporting at least 1 day of OAH, INCS azelastine-fluticasone. assessed weeks during which answered questionnaire on all days. restricted our analyses provided between January June, encompass pollen seasons across different countries. analysed symptoms using visual analogue scales (VASs) combined symptom-medication score (CSMS), performing stratified by weekly levels. Medication was computed as proportion days reported medication use. Sensitivity were performed considering most missing months 4 data. 8212 complete (1361 users). (use > 80% days) specific drug classes ranged 31.7% for 38.5% OAH. Similar found without asthma, except (better asthma patients). VAS CSMS levels increased no full adherence, INCS. A higher uncontrolled observed adherence. In weeks, 41.2% co-medication. The sensitivity displayed similar results. high MASK-air. Different patterns compared OAH that are likely impact guidelines.

Language: Английский

Citations

1

Asthma and rhinitis control in adolescents and young adults: A real‐world MASK‐air study DOI Creative Commons
Bernardo Sousa‐Pinto, Arūnas Valiulis, Erik Melén

et al.

Pediatric Allergy and Immunology, Journal Year: 2024, Volume and Issue: 35(2)

Published: Feb. 1, 2024

Abstract Background In allergic rhinitis and asthma, adolescents young adult patients are likely to differ from older patients. We compared adolescents, adults on symptoms, control levels, medication adherence. Methods a cross‐sectional study (2015–2022), we assessed European users of the MASK‐air mHealth app three age groups: (13–18 years), (18–26 (>26 years). them their reported asthma use adherence treatment Allergy symptoms were by means visual analogue scales (VASs) or combined symptom‐medication score (CSMS), electronic daily for (e‐DASTHMA). built multivariable regression models compare accounting potential differences in demographic characteristics baseline severity. Results 965 adolescent (15,252 days), 4595 (58,161 15,154 (258,796 days). Users all groups displayed similar models, not found significantly medication. These also that lower VAS global allergy, ocular, (as well as CSMS) than adults. Conclusions Adolescents better adults, even though levels observed across groups. results pave way future studies understanding how diseases.

Language: Английский

Citations

7

EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR DOI Creative Commons

G. K. Scadding,

Diego M. Conti, Sophie Scheire

et al.

Frontiers in Allergy, Journal Year: 2025, Volume and Issue: 5

Published: Feb. 3, 2025

Allergic rhinitis (AR), the most prevalent immunological disease, affects approximately 400 million individuals globally and can significantly impact quality of life (QoL). Despite nearly 25 years guidelines, AR remains largely under- diagnosed, suboptimally treated poorly controlled. In light new knowledge treatment options, there is a necessity to update or revise fundamental definitions facilitate communication across diverse specialties engaged in its improve patient care. The European Forum for Research Education Allergy Airway Diseases (EUFOREA) convened meeting experts representatives deliberate optimal methodology measuring responses establishing novel goals. This paper presents consensus on revised definitions, including control, severe allergic rhinoconjunctivitis (SARC), refractory (R-SARC), remission, resolution, improvement, exacerbation, treatable traits (TTs), treat target, relapse, progression, disease modification, prevention.

Language: Английский

Citations

0

Macrophage-mediated activation of the IL4I1/AhR axis is a key player in allergic rhinitis DOI
Qian Liu,

Guohao Deng,

Xian Jiang

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 152, P. 114439 - 114439

Published: March 12, 2025

Language: Английский

Citations

0

Research Progress in Diagnosis and Treatment of Rhinitis in Children DOI

文鸽 徐

Advances in Clinical Medicine, Journal Year: 2025, Volume and Issue: 15(03), P. 2039 - 2045

Published: Jan. 1, 2025

Language: Английский

Citations

0

Bibliometric Perspectives on Inflammatory and Immunological Research in Pediatric Asthma DOI
Danqing Hu,

Ling Mei,

Dongyang An

et al.

Journal of Asthma, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 17

Published: April 20, 2025

Pediatric bronchial asthma, a prevalent chronic inflammatory respiratory disease, significantly affects children globally. However, bibliometric analyses focused on its and immunological aspects are limited. This study aims to provide an overview of the field, identify key focus areas, predict emerging trends. We collected analyzed relevant literature published from January 1, 2000, May 31, 2024, Web Science Core Collection. Collaborative network analysis was conducted using CiteSpace 5.8.R3, VOSviewer 1.6.20, Bibliometrix. A total 911 papers were retrieved, showing growth in research output since 2006, with United States leading publications. The University Western Australia ranks first publication count, while Wisconsin-Madison has highest average citations per paper. Among 5,059 authors, 146 core authors contributed 592 articles, accounting for 64.98% publications, Anne M. Fitzpatrick as author. journal "Allergy, Asthma & Immunology Reviews" is most influential, "asthma" cited keyword. Co-citation reveals 20 keyword clusters, hotspots including "efficacy" "allergic rhinitis." paper by D. P. Strachan "British Medical Journal." significant increase pediatric asthma 2000 U.S. scholarly contributions. Key findings highlight allergic airway inflammation type 2 primary mechanisms underlying disease. Inhaled corticosteroids biologics identified effective treatments. These insights emphasize importance global collaboration ongoing efforts advance understanding pathogenic clinical management patients.

Language: Английский

Citations

0

ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist DOI
Giovanni Paoletti, Corrado Giua,

Alessandro Marti

et al.

World Allergy Organization Journal, Journal Year: 2025, Volume and Issue: 18(5), P. 101055 - 101055

Published: April 25, 2025

Language: Английский

Citations

0

Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024) DOI Creative Commons
Jean Bousquet, Holger J. Schünemann,

Bernardo Sousa-Pinto

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: 12(10), P. 2648 - 2668.e2

Published: July 4, 2024

The traditional healthcare model is focused on diseases (medicine and natural science) does not acknowledge patients' resources abilities to be experts in their own lives based lived experiences. Improving safety, quality, coordination, as well quality of life, an important aim the care patients with chronic conditions. Person-centered needs ensure that people's values preferences guide clinical decisions. This paper reviews current knowledge develop (1) digital pathways for rhinitis asthma multimorbidity (2) digitally enabled, person-centered care.

Language: Английский

Citations

3

Action-plan and as-needed therapy in allergic rhinitis DOI Creative Commons
Hyeon‐Jong Yang

Clinical and Experimental Pediatrics, Journal Year: 2024, Volume and Issue: 67(6), P. 267 - 273

Published: May 21, 2024

Action-plan is a written set of instructions that helps patient manage their symptoms and respond to worsening condition. The action-plan usually includes information on how recognize, treat, prevent symptoms. plan also understand when use medications, much use, often them as-needed. An should be developed through discussion between the physician, reflecting patient's severity, preferences, values regularly updated reflect changes in person's In asthma, action-plans as-needed therapy are already well utilized. Unlike importance an has been overlooked allergic rhinitis (AR), but its recently recognized. AR chronic condition affects people differently, can cause range symptoms, including nasal congestion, runny nose, sneezing, itching, watery eyes. Therefore, help patients these more effectively, reducing impact daily activities quality life. Furthermore, it tailored meet personal needs each patient, based severity triggers, overall health. Because adhere treatment regimen by providing clear take medication, stay track with treatment, likelihood missed doses failures. Overall, important components comprehensive for AR. They improve symptom control, complications, promote adherence leading better outcomes higher

Language: Английский

Citations

2